BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32379941)

  • 1. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
    Xu SL; Tian YY; Zhou Y; Liu LQ
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of microRNAs in discriminating malignant thyroid nodules from benign ones on fine-needle aspiration samples.
    Zhang Y; Zhong Q; Chen X; Fang J; Huang Z
    Tumour Biol; 2014 Sep; 35(9):9343-53. PubMed ID: 24943685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.
    Zi Y; Yin Z; Xiao W; Liu X; Gao Z; Jiao L; Deng L
    Mol Neurobiol; 2015 Dec; 52(3):1494-1503. PubMed ID: 25367880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as novel biomarkers for the differentiation of malignant versus benign thyroid lesions: a meta-analysis.
    Zhou GJ; Xiao M; Zhao LN; Tang JG; Zhang L
    Genet Mol Res; 2015 Jul; 14(3):7279-89. PubMed ID: 26214406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating MicroRNAs as Potential Diagnostic Biomarkers for Diabetic Retinopathy: A Meta-Analysis.
    Ma L; Wen Y; Li Z; Wu N; Wang Q
    Front Endocrinol (Lausanne); 2022; 13():929924. PubMed ID: 35898469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs as Potential Biomarkers for the Diagnosis of Endometrial Cancer: a Meta-Analysis.
    Gao J; Fan YZ; Gao SS; Zhang WT
    Reprod Sci; 2023 Feb; 30(2):464-472. PubMed ID: 35764858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
    Chen L; Cui Z; Liu Y; Bai Y; Lan F
    Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis.
    Wu N; Sun H; Sun Q; Zhang F; Ma L; Hu Y; Cong X
    BMC Cancer; 2023 May; 23(1):414. PubMed ID: 37158840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of circulating microRNAs for gastric cancer in Asian populations: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):11995-2004. PubMed ID: 25159040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
    Cui Y; Hong S; Zhu X
    Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
    Zhang WT; Zhang GX; Zhao RZ; Gao SS
    Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis.
    Wang X; Kong D; Wang C; Ding X; Zhang L; Zhao M; Chen J; Xu X; Hu X; Yang J; Gao S
    J Ovarian Res; 2019 Mar; 12(1):24. PubMed ID: 30898156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Shoghi A; Mesgari M; Amirabadi A; Sahebkar A
    Expert Rev Mol Diagn; 2022 Feb; 22(2):201-211. PubMed ID: 34906021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta analysis of the diagnostic value of circulating miRNA in benign and malignant pulmonary nodules.
    Hong Z; Cui B; Bai X; Li H; Cheng T; Sheng Y; Lu Y; Wu X; Jin D; Zhao J; Gou Y
    World J Surg Oncol; 2023 Sep; 21(1):284. PubMed ID: 37689670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA panels as diagnostic biomarkers for colorectal cancer: A systematic review and meta-analysis.
    Sur D; Advani S; Braithwaite D
    Front Med (Lausanne); 2022; 9():915226. PubMed ID: 36419785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as novel biomarkers in the diagnosis of prostate cancer: a systematic review and meta-analysis.
    Yin C; Fang C; Weng H; Yuan C; Wang F
    Int Urol Nephrol; 2016 Jul; 48(7):1087-95. PubMed ID: 27068818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.
    Ma C; Nguyen HPT; Luwor RB; Stylli SS; Gogos A; Paradiso L; Kaye AH; Morokoff AP
    PLoS One; 2018; 13(2):e0189452. PubMed ID: 29444091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as ideal biomarkers for the diagnosis of lung cancer.
    Guo Z; Zhao C; Wang Z
    Tumour Biol; 2014 Oct; 35(10):10395-407. PubMed ID: 25053595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.